Danaher Corporation
Could not find a ticker for this position, may be a filing error
A maker of instruments, consumables, and services for biological research and healthcare, Danaher serves labs, hospitals, and drug developers through brands like Beckman Coulter, Cytiva, Pall, and Leica Microsystems. The company was formed in 1984, and the founding brothers named it after Danaher Creek in Montana, where they were fly fishing when they hatched the idea for the business.
Debt Note
Sold 1.25M
Sold 1.08M
Granted 3.3K · Sold 3.3K
Granted 12.2K · Sold 2.6K
Granted 31.3K · Sold 22.4K
Granted 8.2K
Granted 8.9K
Granted 16.1K
Granted 5.6K · Sold 3.9K
Granted 103.0K · Sold 142.5K
Granted 72.0K · Sold 78.7K
Granted 19.1K
Granted 12.2K · Sold 9.4K
Granted 29.4K · Sold 15.8K
Granted 4.0K
Granted 14.4K
Granted 33.1K · Sold 41.1K
Granted 15.9K
Granted 1.6K
Granted 12.5K
Granted 53.5K · Sold 73.0K
Granted 3.5K
Granted 6.3K · Sold 1.3K
Granted 14.4K · Sold 8.7K
Granted 1.6K
Granted 390
Granted 1.6K
Granted 967
Granted 1.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Rales Steven MChairman, Director · 8 transactions | -1.5% | 34.85Mas of May 2025 | — | — | 1.25M |
| Rales Mitchell PChairman of Exec. Committee, Director · 12 transactions | +567.5% | 27.56M | — | — | 1.08M |
| Lohr Walter GDirector · 2 transactions | +1.2% | 408.4Kas of Feb 2024 | 3.3K | — | 3.3K |
| Spoon Alan GDirector · 9 transactions | +14.3% | 133.5K | 12.2K | — | 2.6K |
| Weidemanis JoakimExecutive Vice President · 6 transactions | -21.4% | 87.3Kas of May 2024 | 31.3K | — | 22.4K |
| Schwieters John TDirector · 6 transactions | +8.6% | 57.3Kas of Jul 2025 | 8.2K | — | — |
| Zerhouni Elias A.Director · 7 transactions | +33.3% | 50.7K | 8.9K | — | — |
| King WilliamSVP, Strategic Development · 4 transactions | +15.5% | 48.2Kas of May 2024 | 16.1K | — | — |
| Filler LindaDirector · 5 transactions | — | 46.3K | 5.6K | — | 3.9K |
| Blair RainerPresident & CEO, Director · 20 transactions | — | 38.0K | 103.0K | — | 142.5K |
| McGrew MatthewExecutive Vice President · 16 transactions | -36.8% | 37.1K | 72.0K | — | 78.7K |
| Sawyer Montgomery Julie AExecutive Vice President · 9 transactions | — | 22.2K | 19.1K | — | — |
| List TeriDirector · 10 transactions | +22.7% | 21.5K | 12.2K | — | 9.4K |
| Riley Christopher PaulExecutive Vice President · 14 transactions | — | 20.4K | 29.4K | — | 15.8K |
| Gugino Matthew EEVP & Chief Financial Officer · 2 transactions | — | 19.5K | 4.0K | — | — |
| Gutierrez-Ramos Jose-CarlosSVP, Chief Science Officer · 10 transactions | +174.1% | 19.0K | 14.4K | — | — |
| Ellis Brian WSenior Vice President · 13 transactions | -56.1% | 15.0K | 33.1K | — | 41.1K |
| Gray R BradleySVP Strategic Development · 3 transactions | — | 14.5K | 15.9K | — | — |
| Stevens Raymond CDirector · 3 transactions | +51.1% | 13.7K | 1.6K | — | — |
| Leiken JonathanSVP-Chief Legal Officer · 2 transactions | — | 12.5K | 12.5K | — | — |
| Raskas DanielSVP - Corporate Development · 10 transactions | -78.7% | 10.5Kas of Feb 2025 | 53.5K | — | 73.0K |
| Bouda ChristopherVP, Chief Accounting Officer · 11 transactions | +40.4% | 9.8K | 3.5K | — | — |
| Milosevich Gregory MExecutive Vice President · 7 transactions | — | 9.1K | 6.3K | — | 1.3K |
| Couchara GeorgeannSVP, Human Resources · 19 transactions | +120% | 8.3K | 14.4K | — | 8.7K |
| Sanders A ShaneDirector · 3 transactions | +189.2% | 5.9K | 1.6K | — | — |
| Sabeti Pardis CDirector · 1 transaction | +37% | 5.3Kas of May 2024 | 390 | — | — |
| Dewan FerozDirector · 3 transactions | +316.6% | 4.7K | 1.6K | — | — |
| Mega Jessica LDirector · 2 transactions | +59.4% | 3.3Kas of May 2025 | 967 | — | — |
| Lamanna Charles WDirector · 3 transactions | — | 1.4K | 1.4K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -2.73M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.